[1] 蒋均,潘晓红,杨介者,等.浙江省4家综合性医院就诊者丙型肝炎病毒抗体检测结果分析[J].中国艾滋病性病,2020,26(3):250-253.DOI:10.13419/j.cnki.aids.2020.03.07.
[2] Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection?[J]. Auto Immun Highlights, 2017,8(1):9. DOI: 10.1007/s13317-017-0097-2.
[3] 陈剑锋,常乐,刘虹,等.两种化学发光免疫分析试剂用于血液筛查丙肝抗体的检测性能评价[J].中国输血杂志,2021,34(2):123-127.DOI:10.13303/j.cjbt.issn. 1004-549x. 2021. 02.007.
[4] 李峰.雅培i2000化学发光分析仪检测HCV抗体的假阳性分析[J].中国继续医学教育,2016,8(26):52-53,54.DOI:10.3969/j.issn.1674-9308.2016.26.029.
[5] 王镱达.雅培i2000化学发光分析仪检测HCV抗体的假阳性研究[J].中国医疗器械信息,2021,27(18):70-71.DOI:10.3969/j.issn.1006-6586.2021.18.033.
[6] U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients[J]. MMWR Recomm Rep, 2001,50(RR-5):1-43.
[7] Dufour DR, Talastas M, Fernandez MD, et al. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection[J]. Clin Chem, 2003,49(3):479-486. DOI: 10.1373/49.3.479.
[8] 杜文静,赵欣.酶联免疫法检测血清丙肝抗体假阳性的临床分析[J].医药前沿,2017,7(14):32-33.DOI:10.3969/j.issn.2095-1752.2017.14.032.
[9] Heinrichs A, Antoine M, Steensels D, et al. HCV false positive immunoassays in patients with LVAD: a potential trap![J]. J Clin Virol, 2016,78:44-46. DOI: 10.1016/j.jcv.2016.03.007.
[10] 陆银华,朱宇清,赵晓君,等.不同检测系统抗HCV抗体灰区样本检测一致性分析[J].检验医学,2021,36(7):700-704.DOI:10.3969/j.issn.1673-8640.2021.07.004.
[11] 郭飞波,武军驻.不同HCV抗体检测试剂效果的比较[J].临床肝胆病杂志,2016,32(9):1725-1728.DOI:10.3969/j.issn.1001-5256.2016.09.018.
[12] 李涛,罗兵,金先彬,等.三种酶免试剂盒和电化学发光试剂盒检测HCV抗体的比较[J].安徽医药,2012,16(8):1092-1094.DOI:10.3969/j.issn.1009-6469.2012.08.020.
[13] 李瑞兰,李忠平,樊忠杰,等.HCV抗体检测临界值附近样本传播HCV风险的研究[J].临床输血与检验,2008,10(1):31-35.DOI:10.3969/j.issn.1671-2587.2008.01.010.
[14] 潘洁.罗氏丙肝抗体Ⅱ临界值的确立及几种丙肝抗体方法学比较[D].广州:南方医科大学,2018.
[15] 杨泽. 应用ROC曲线分析ECLIA检测丙肝抗体的最佳S/CO值及在临床检验中的应用[D].沈阳:沈阳医学院,2019.
[16] 曾健,商秀娟,顾芸芸,等.降低化学发光法梅毒抗体检测假阳性的方法[J].中国皮肤性病学杂志,2020,34(9):1091-1094.DOI:10.13735/j.cjdv.1001-7089.202002013.
[17] 黎锦,李一荣.内源性抗体对临床免疫检测的干扰及对策[J].中华检验医学杂志,2016,39(11):811-813.DOI:10.3760/cma.j.issn.1009-9158.2016.11.003.
[18] Batteiger B, Newhall WJ 5th, Jones RB. The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes[J]. J Immunol Methods, 1982,55(3):297-307. DOI: 10.1016/0022-1759(82)90089-8.
[19] 裘宇容,李欣,孙德华,等.嗜异性抗体对检测结果干扰的两例临床病例分析[J].中华检验医学杂志,2013,36(5):470-471.DOI:10.3760/cma.j.issn.1009-9158.2013.05.024.
[20] Arya SK, Zhurauski P, Jolly P, et al. Capacitive aptasensor based on interdigitated electrode for breast cancer detection in undiluted human serum[J]. Biosens Bioelectron, 2018,102:106-112. DOI: 10.1016/j.bios.2017.11.013.
[21] Chiu NHL,Christopoulos TK. Advances in immunoassay technology[M]. Croatia: InTech,2012:45-63.
[22] Warkad SD, Song KS, Pal D, et al. Developments in the HCV screening technologies based on the detection of antigens and antibodies[J]. Sensors (Basel), 2019,19(19):4257. DOI: 10.3390/s19194257.
[23] Huang Y, Pan H, Gao Q, et al. The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations[J]. Sci Rep, 2021,11(1):8689. DOI: 10.1038/s41598-021-88138-2.
[24] 王菊英,魏军,张建荣.HCV抗体反应性标本的RIBA确证结果分析[J].中华检验医学杂志,2011,34(12):1128.DOI:10.3760/cma.j.issn.1009-9158.2011.12.019.
[25] 中华人民共和国国家卫生和计划生育委员会.WS 213-2018丙型肝炎诊断[J].中国病毒病杂志,2018,8(4):248-251. DOI:10.16505/j.2095-0136.2018.0060.
|
